The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Sol-Gel Technologies Ltd(NASDAQ:SLGL) 
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-dail...
Website: http://www.sol-gel.com
Founded: 1997
Full Time Employees: 61
Sector: Healthcare
Industry: Biotechnology
Sol-Gel Technologies Days Payable Outstanding ttm (DPO)
Sol-Gel Technologies Days Receivable Outstanding ttm (DSO)
Sol-Gel Technologies Op Cashflow Per Share ttm
Sol-Gel Technologies Free Cashflow Per Share ttm
Sol-Gel Technologies Cash Per Share ttm
Sol-Gel Technologies P/S ratio ttm
Sol-Gel Technologies (GAAP) P/E ratio ttm
Sol-Gel Technologies P/B ratio ttm
No extra charts and metrics for this ticker.